We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 43

Astrazeneca v. Apotex, interlocutory motion to strike affidavit in PMNOC Regulations case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

This was an appeal to the Federal Court of Appeal (FCA) of the decision of Justice Hughes refusing to strike an affidavit from the record

Merck v Apotex, PMNOC proceedings, dorzolamide, October 22, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 24 2010

This proceeding for an order of prohibition was a companion case to the case described below

Eli Lilly Canada Inc. v. Apotex Inc (2010 FCA 240)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

This was an appeal of the decision of Madame Justice Gauthier (in the Federal Court) who had found that although Lilly met its burden to prove that Apotex infringed eight Lilly process patents related to the manufacture of the antibiotic cefaclor for material imported before June 3, 1998, Lilly failed to do so for the cefaclor imported into Canada after June 3, 1998

Novopharm Limited v. Eli Lilly and Company (2010 FC 915)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

An impeachment action was brought by Novopharm in respect of a patent for STRATTERA alleging obviousness, anticipation, utility and improper selection

Epicept Corporation v. Canada (Health) (2010 FC 956)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

The Minister of Health refused to grant data exclusivity to data from Epicept’s phase I and phase II clinical trials because CEPLENE is not an “innovative drug”

Apotex loses the war in Canada and the battle in England: UK courts rely on Canadian decision to find Apotex acting unlawfully in cCnada has consequences in eErope

  • Gowling Lafleur Henderson LLP
  • -
  • Canada, United Kingdom
  • -
  • October 13 2011

Servier developed perindopril erbumine (“perindopril”) which is a successful long lasting ACE inhibitor sold under the trade-mark COVERSYL

Apotex v. Pfizer, motion to strike part of a defence pertaining to res judicata, sildenafil citrate, June 11, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 16 2010

Apotex applied to impeach Pfizer's patent for Viagra and Pfizer defended alleging, in part, res judicata

Apotex v Syntex and Roche, dismissal of appeal concerning section 8 of PMNOC Regulations, naproxen, June 10, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 16 2010

Apotex had sued Roche for damages pursuant to s. 8 of the PMNOC Regulations

Novopharm v. The Minister of Health, motion for a confidentiality order in a judicial review application of decision of Minister of Health, drug name confidential, May 26, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 16 2010

The Minister decided that before a NOC could be issued to Novopharm, Novopharm must address a specific patent on the Patent Register

Pfizer v. Novopharm, appeal of decision of prothonotary to deny Novopharm’s motion for confidentiality in PMNOC Regulations case, pregabalin, June 21, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 16 2010

Novopharm served a NOA on Pfizer which it had unilaterally designated confidential